Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mach7 TechnologiesASX:M7T 45 EV-to-OCF is -155.31 as of Aug. 12, 2026. GuruFocus rates ASX:M7T with a GF Score™ of 45/100 and a GF Value™ of A$0.86 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Mach7 Technologies ranks better than 98.1% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Mach7 Technologies's Enterprise Value is A$48.30 Mil.
Mach7 Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.31 Mil. Therefore, Mach7 Technologies's EV-to-OCF for today is -155.31.
The historical rank and industry rank for Mach7 Technologies's EV-to-OCF or its related term are showing as below:
ASX:M7T'
s EV-to-OCF Range Over the Past 10 Years
Min: -159.09 Med: 15.61 Max: 161.26
Current: -159.09
During the past 13 years, the highest EV-to-OCF of Mach7 Technologies was 161.26. The lowest was -159.09. And the median was 15.61.
ASX:M7T's EV-to-OCF is ranked better than 98.1% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 8.91
vs ASX:M7T: -159.09
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Mach7 Technologies's PE Ratio (TTM) for today is calculated as:
Mach7 Technologies's share price for today is A$0.28.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mach7 Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.042.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Mach7 Technologies EV-to-OCF Related Terms
Mach7 Technologies EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Mach7 Technologies's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Mach7 Technologies's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mach7 Technologies EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Mach7 Technologies's EV-to-OCF falls into.
Mach7 Technologies's current Enterprise Value is A$48.30 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mach7 Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.31 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mach7 Technologies (ASX:M7T) has a EV-to-OCF of -155.31 as of Aug. 12, 2026. According to the industry distribution chart, Mach7 Technologies ranks #13 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 1.9%.
Is Mach7 Technologies' EV-to-OCF too high?
Mach7 Technologies' current EV-to-OCF is -155.31. Based on the distribution chart, Mach7 Technologies ranks #13 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Mach7 Technologies has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mach7 Technologies' EV-to-OCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mach7 Technologies ranks #13 out of 683 companies for EV-to-OCF. This places Mach7 Technologies in the top 2% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 8.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.91, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mach7 Technologies's current EV-to-OCF is -155.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mach7 Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mach7 Technologies (ASX:M7T) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.86, compared to a current price of A$0.28 — trading 67.4% below its estimated fair value. The current EV-to-OCF is -155.31. Mach7 Technologies' overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Mach7 Technologies (ASX:M7T), the current EV-to-OCF is -155.31 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mach7 Technologies (ASX:M7T) Overvalued in 2026?
Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued.
The current stock price of A$0.28 is trading 67.4% below its estimated GF Value™ of A$0.86.
GuruFocus considers Mach7 Technologies to be Possible Value Trap.
Key valuation signals for ASX:M7T:
EV-to-OCF: -155.31
GF Value™: A$0.86 vs. price of A$0.28 (67.4% below fair value)
No single metric tells the full story. See the ASX:M7T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
45GF Score
Get the complete analysis for ASX:M7T
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:M7T has been successfully added to your 
